Invion

Subscribe to receive announcements and updates from Invion.

New investors

Home

Announcements

Updates

Lato

upload.jpg

Find out more about Invion's (ASX: IVX) theragnostic potential!

Early data release by Invion suggests the Photosoft technology can see cancers (diagnostic), and can kill cancers (therapeutic) with the same drug INV043.

Violet light makes the cancer visible (fluoresce).

Red light reduces cancer size (Statistically significant early data)

INV043 is pain-free application and no serious events support expansion into INV043/PD-1 inhibitor trial for rare diseases.

Event: Live Interview with Thian Chew, Chairman & CEO 
Time: Thursday, 5 June at 2:00PM (AEST)
Join the Live Interview Here: https://equity-story.whereby.com/ceo-interviews25dc9510-1270-4612-a3f2-41de9fa65d90

Equity Story Webinar Invitation: Exclusive Interview with Prof Thian Chew - Thurs, 5th June at 2:00PM (AEST)